P2.09. MRI Radiomics Approach to Predict the Intracranial Efficacy of the Third Generation EGFR-TKI Osimertinib in NSCLC Patients with Brain Metastases - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
Xin Tang
Meta Tag
Speaker Xin Tang
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
Keywords
brain MRI radiomics
third-generation EGFR-TKI osimertinib
treating brain metastases
non-small cell lung cancer
NSCLC patients
blood-brain barrier
predictive accuracy
radiomic model
intracranial progression-free survival
personalized treatment strategies
Powered By